Our corporate headquarters is located at 152 West 57th Street, 21st Floor, New York, NY.
Thorne HealthTech's initial public offering was on September 23, 2021.
Our fiscal year runs from January 1 through December 31.
Thorne HealthTech stock is traded on the NASDAQ Global Select Market under the ticker symbol THRN.
Our transfer agent is Computershare Investor Services.
We do not have a Direct Stock Purchase Plan. To purchase shares of Thorne HealthTech you must contact a registered full service or discount broker.
Thorne HealthTech’s common stock can be purchased on the open market through a registered broker.
Thorne HealthTech's CUSIP is 885260 109.
Our independent auditor is BDO USA, LLP.
Please visit the Email Alerts section of our website.
Please contact Thorne HealthTech investor relations department at investors@thorne.com.
Please fill out our customer service form here.